keyword
https://read.qxmd.com/read/38682490/trp-channels-in-excitotoxicity
#1
REVIEW
Pengyu Zong, Nicholas Legere, Jianlin Feng, Lixia Yue
Glutamate excitotoxicity is a central mechanism contributing to cellular dysfunction and death in various neurological disorders and diseases, such as stroke, traumatic brain injury, epilepsy, schizophrenia, addiction, mood disorders, Huntington's disease, Alzheimer's disease, Parkinson's disease, multiple sclerosis, pathologic pain, and even normal aging-related changes. This detrimental effect emerges from glutamate binding to glutamate receptors, including α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, N -methyl-d-aspartate receptors, kainate receptors, and GluD receptors...
April 29, 2024: Neuroscientist: a Review Journal Bringing Neurobiology, Neurology and Psychiatry
https://read.qxmd.com/read/38677698/multi-omics-analysis-identifies-sex-specific-hepatic-protein-metabolite-networks-in-yellow-catfish-pelteobagrus-fulvidraco-exposed-to-chronic-hypoxia
#2
JOURNAL ARTICLE
Cheng Zhao, Yufeng Song, Guosong Zhang, Kai Zhang, Shaowu Yin, Jie Ji
Hypoxia disrupts the endocrine system of teleosts. The liver plays important roles in the endocrine system, energy storage, and metabolic processes. The aim of this study was to investigate the sex-specific hepatic response of yellow catfish under chronic hypoxia at the multi-omics level. Common hepatic responses in both sexes included the HIF-1 signaling pathway, glycolysis/gluconeogenesis, and steroid biosynthesis. Hypoxia dysregulated primary bile acid biosynthesis, lipid metabolism, and vitellogenin levels in female fish...
April 25, 2024: International Journal of Biological Macromolecules
https://read.qxmd.com/read/38676932/neurodegenerative-disease-pathways-are-perturbed-in-patients-with-cancer-who-self-report-cognitive-changes-and-anxiety-a-pathway-impact-analysis
#3
JOURNAL ARTICLE
Kate R Oppegaard, Samantha J Mayo, Terri S Armstrong, Vasuda Dokiparthi, Michelle Melisko, Jon D Levine, Adam B Olshen, Joaquin A Anguera, Ritu Roy, Steven Paul, Bruce Cooper, Yvette P Conley, Marilyn J Hammer, Christine Miaskowski, Kord M Kober
BACKGROUND: Cancer-related cognitive impairment (CRCI) and anxiety co-occur in patients with cancer. Little is known about mechanisms for the co-occurrence of these two symptoms. The purposes of this secondary analysis were to evaluate for perturbed pathways associated with the co-occurrence of self-reported CRCI and anxiety in patients with low versus high levels of these two symptoms and to identify potential mechanisms for the co-occurrence of CRCI and anxiety using biological processes common across any perturbed neurodegenerative disease pathways...
April 27, 2024: Cancer
https://read.qxmd.com/read/38674383/predictive-role-of-cluster-bean-cyamopsis-tetragonoloba-derived-mirnas-in-human-and-cattle-health
#4
JOURNAL ARTICLE
Sarika Sahu, Atmakuri Ramakrishna Rao, Tanmaya Kumar Sahu, Jaya Pandey, Shivangi Varshney, Archna Kumar, Kishor Gaikwad
MicroRNAs (miRNAs) are small non-coding conserved molecules with lengths varying between 18-25nt. Plants miRNAs are very stable, and probably they might have been transferred across kingdoms via food intake. Such miRNAs are also called exogenous miRNAs, which regulate the gene expression in host organisms. The miRNAs present in the cluster bean, a drought tolerant legume crop having high commercial value, might have also played a regulatory role for the genes involved in nutrients synthesis or disease pathways in animals including humans due to dietary intake of plant parts of cluster beans...
April 1, 2024: Genes
https://read.qxmd.com/read/38673007/elucidating-the-impact-of-deleterious-mutations-on-ighg1-and-their-association-with-huntington-s-disease
#5
JOURNAL ARTICLE
Alaa Shafie, Amal Adnan Ashour, Farah Anjum, Anas Shamsi, Md Imtaiyaz Hassan
Huntington's disease (HD) is a chronic, inherited neurodegenerative condition marked by chorea, dementia, and changes in personality. The primary cause of HD is a mutation characterized by the expansion of a triplet repeat (CAG) within the huntingtin gene located on chromosome 4. Despite substantial progress in elucidating the molecular and cellular mechanisms of HD, an effective treatment for this disorder is not available so far. In recent years, researchers have been interested in studying cerebrospinal fluid (CSF) as a source of biomarkers that could aid in the diagnosis and therapeutic development of this disorder...
April 1, 2024: Journal of Personalized Medicine
https://read.qxmd.com/read/38670061/the-influence-of-chronic-inflammation-on-the-illnesscourse-of-bipolar-disorder-a-longitudinal-study
#6
JOURNAL ARTICLE
Robert Queissner, Frederike T Fellendorf, Nina Dalkner, Susanne A Bengesser, Alexander Maget, Armin Birner, Martina Platzer, Bernd Reininghaus, Alfred Häussl, Elena Schönthaler, Adelina Tmava-Berisha, Melanie Lenger, Eva Z Reininghaus
INTRODUCTION: C-reactive protein (CRP) is a systemic inflammatory marker, which indicates systemic inflammatory processes It is involved in different inflammatory processes of the body and is a reliable marker for the general inflammatory state of the body. High sensitive CRP seems to play a key role as a state and trait marker of bipolar disorder (BD). In the current study, we tried to determine the long-term effect of CRP levels on clinical symptoms and illness course of bipolar disorder...
April 13, 2024: Journal of Psychiatric Research
https://read.qxmd.com/read/38669553/clinical-review-of-juvenile-huntington-s-disease
#7
REVIEW
Mayke Oosterloo, Alexiane Touze, Lauren M Byrne, Jannis Achenbach, Hande Aksoy, Annabelle Coleman, Dawn Lammert, Martha Nance, Peggy Nopoulos, Ralf Reilmann, Carsten Saft, Helen Santini, Ferdinando Squitieri, Sarah Tabrizi, Jean-Marc Burgunder, Oliver Quarrell
 Juvenile Huntington's disease (JHD) is rare. In the first decade of life speech difficulties, rigidity, and dystonia are common clinical motor symptoms, whereas onset in the second decade motor symptoms may sometimes resemble adult-onset Huntington's disease (AOHD). Cognitive decline is mostly detected by declining school performances. Behavioral symptoms in general do not differ from AOHD but may be confused with autism spectrum disorder or attention deficit hyperactivity disorder and lead to misdiagnosis and/or diagnostic delay...
April 26, 2024: Journal of Huntington's Disease
https://read.qxmd.com/read/38667285/exosomes-in-vascular-neurological-disorders-and-the-road-ahead
#8
REVIEW
Faisal A Alzahrani, Yasir M Riza, Thamir M Eid, Reema Almotairi, Lea Scherschinski, Jessica Contreras, Muhammed Nadeem, Sylvia E Perez, Sudhanshu P Raikwar, Ruchira M Jha, Mark C Preul, Andrew F Ducruet, Michael T Lawton, Kanchan Bhatia, Naseem Akhter, Saif Ahmad
Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), Huntington's disease (HD), stroke, and aneurysms, are characterized by the abnormal accumulation and aggregation of disease-causing proteins in the brain and spinal cord. Recent research suggests that proteins linked to these conditions can be secreted and transferred among cells using exosomes. The transmission of abnormal protein buildup and the gradual degeneration in the brains of impacted individuals might be supported by these exosomes...
April 12, 2024: Cells
https://read.qxmd.com/read/38666850/role-of-tfeb-in-huntington-s-disease
#9
REVIEW
Javier Ojalvo-Pacheco, Sokhna M S Yakhine-Diop, José M Fuentes, Marta Paredes-Barquero, Mireia Niso-Santano
Huntington's disease (HD) is an autosomal dominant neurodegenerative disease caused by an expansion of the CAG trinucleotide repeat in exon 1 of the huntingtin (HTT) gene. This expansion leads to a polyglutamine (polyQ) tract at the N-terminal end of HTT, which reduces the solubility of the protein and promotes its accumulation. Inefficient clearance of mutant HTT (mHTT) by the proteasome or autophagy-lysosomal system leads to accumulation of oligomers and toxic protein aggregates in neurons, resulting in impaired proteolytic systems, transcriptional dysregulation, impaired axonal transport, mitochondrial dysfunction and cellular energy imbalance...
April 4, 2024: Biology
https://read.qxmd.com/read/38661189/exploring-potential-developmental-origins-of-common-neurodegenerative-disorders
#10
JOURNAL ARTICLE
James P Catlin, Christine E Schaner Tooley
In the United States, it is now estimated that 6.7 million people over the age of 65 are afflicted by Alzheimer's disease (AD), over 1 million people are living with Parkinson's disease (PD), and over 200 000 have or are at risk for developing Huntington's disease (HD). All three of these neurodegenerative diseases result in the ultimate death of distinct neuronal subtypes, and it is widely thought that age-related damage is the single biggest contributing factor to this neuronal death. However, recent studies are now suggesting that developmental defects during early neurogenesis could also play a role in the pathology of neurodegenerative diseases...
April 25, 2024: Biochemical Society Transactions
https://read.qxmd.com/read/38660915/copper-enhances-aggregational-toxicity-of-mutant-huntingtin-in-a-drosophila-model-of-huntington-s-disease
#11
JOURNAL ARTICLE
Amanda G Lobato, Natalie Ortiz-Vega, Yi Zhu, Deepa Neupane, Katlyn K Meier, R Grace Zhai
Huntington's disease (HD) is a progressive neurodegenerative disorder with clinical presentations of moderate to severe cognitive, motor, and psychiatric disturbances. HD is caused by the trinucleotide repeat expansion of CAG of the huntingtin (HTT) gene. The mutant HTT protein containing pathological polyglutamine (polyQ) extension is prone to misfolding and aggregation in the brain. It has previously been observed that copper and iron concentrations are increased in the striata of post-mortem human HD brains...
January 2024: Biochimica et Biophysica Acta. Molecular Basis of Disease
https://read.qxmd.com/read/38657047/hypk-a-marginally-disordered-protein-sensitive-to-charge-decoration
#12
JOURNAL ARTICLE
Arash Firouzbakht, Austin Haider, Kari Gaalswyk, Sepehr Alaeen, Kingshuk Ghosh, Martin Gruebele
Intrinsically disordered proteins (IDPs) that lie close to the empirical boundary separating IDPs and folded proteins in Uversky's charge-hydropathy plot may behave as "marginal IDPs" and sensitively switch conformation upon changes in environment (temperature, crowding, and charge screening), sequence, or both. In our search for such a marginal IDP, we selected Huntingtin-interacting protein K (HYPK) near that boundary as a candidate; PKIα, also near that boundary, has lower secondary structure propensity; and Crk1, just across the boundary on the folded side, has higher secondary structure propensity...
April 30, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38654124/endogenous-mutant-huntingtin-alters-the-corticogenesis-via-lowering-golgi-recruiting-arf1-in-cortical-organoid
#13
JOURNAL ARTICLE
Yang Liu, Xinyu Chen, Yunlong Ma, Chenyun Song, Jixin Ma, Cheng Chen, Jianzhong Su, Lixiang Ma, Hexige Saiyin
Pathogenic mutant huntingtin (mHTT) infiltrates the adult Huntington's disease (HD) brain and impairs fetal corticogenesis. However, most HD animal models rarely recapitulate neuroanatomical alterations in adult HD and developing brains. Thus, the human cortical organoid (hCO) is an alternative approach to decode mHTT pathogenesis precisely during human corticogenesis. Here, we replicated the altered corticogenesis in the HD fetal brain using HD patient-derived hCOs. Our HD-hCOs had pathological phenotypes, including deficient junctional complexes in the neural tubes, delayed postmitotic neuronal maturation, dysregulated fate specification of cortical neuron subtypes, and abnormalities in early HD subcortical projections during corticogenesis, revealing a causal link between impaired progenitor cells and chaotic cortical neuronal layering in the HD brain...
April 23, 2024: Molecular Psychiatry
https://read.qxmd.com/read/38653938/neuroinflammation-and-the-role-of-epigenetic-based-therapies-for-huntington-s-disease-management-the-new-paradigm
#14
REVIEW
Pooja Temgire, Richmond Arthur, Puneet Kumar
Huntington's disease (HD) is an inherited, autosomal, neurodegenerative ailment that affects the striatum of the brain. Despite its debilitating effect on its patients, there is no proven cure for HD management as of yet. Neuroinflammation, excitotoxicity, and environmental factors have been reported to influence the regulation of gene expression by modifying epigenetic mechanisms. Aside focusing on the etiology, changes in epigenetic mechanisms have become a crucial factor influencing the interaction between HTT protein and epigenetically transcribed genes involved in neuroinflammation and HD...
April 23, 2024: Inflammopharmacology
https://read.qxmd.com/read/38651012/exploring-neurodegenerative-disorders-using-advanced-magnetic-resonance-imaging-of-the-glymphatic-system
#15
REVIEW
Jannik Prasuhn, Jiadi Xu, Jun Hua, Peter van Zijl, Linda Knutsson
The glymphatic system, a macroscopic waste clearance system in the brain, is crucial for maintaining neural health. It facilitates the exchange of cerebrospinal and interstitial fluid, aiding the clearance of soluble proteins and metabolites and distributing essential nutrients and signaling molecules. Emerging evidence suggests a link between glymphatic dysfunction and the pathogenesis of neurodegenerative disorders, including Alzheimer's, Parkinson's, and Huntington's disease. These disorders are characterized by the accumulation and propagation of misfolded or mutant proteins, a process in which the glymphatic system is likely involved...
2024: Frontiers in Psychiatry
https://read.qxmd.com/read/38649395/external-evaluation-of-a-deep-learning-based-approach-for-automated-brain-volumetry-in-patients-with-huntington-s-disease
#16
JOURNAL ARTICLE
Robert Haase, Nils Christian Lehnen, Frederic Carsten Schmeel, Katerina Deike, Theodor Rüber, Alexander Radbruch, Daniel Paech
A crucial step in the clinical adaptation of an AI-based tool is an external, independent validation. The aim of this study was to investigate brain atrophy in patients with confirmed, progressed Huntington's disease using a certified software for automated volumetry and to compare the results with the manual measurement methods used in clinical practice as well as volume calculations of the caudate nuclei based on manual segmentations. Twenty-two patients were included retrospectively, consisting of eleven patients with Huntington's disease and caudate nucleus atrophy and an age- and sex-matched control group...
April 22, 2024: Scientific Reports
https://read.qxmd.com/read/38648559/cost-effectiveness-of-adding-quizartinib-to-induction-chemotherapy-for-patients-with-flt3-mutant-acute-myeloid-leukemia
#17
JOURNAL ARTICLE
Jan Philipp Bewersdorf, Kishan K Patel, Rory M Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Huntington, George Goshua, Amer M Zeidan
The FLT3 inhibitor quizartinib has been shown to improve overall survival when added to intensive induction chemotherapy ("7 + 3") in patients 18-75 years old with newly diagnosed AML harboring a FLT3- ITD mutation. However, the health economic implications of this approval are unknown. We evaluated the cost-effectiveness of quizartinib using a partitioned survival analysis model. One-way and probabilistic sensitivity analyses were conducted. In the base case scenario, the addition of quizartinib to 7 + 3 resulted in incremental costs of $289,932 compared with 7 + 3 alone...
April 22, 2024: Leukemia & Lymphoma
https://read.qxmd.com/read/38647433/practical-three-component-regioselective-synthesis-of-drug-like-3-aryl-or-heteroaryl-5-6-dihydrobenzo-h-cinnolines-as-potential-non-covalent-multi-targeting-inhibitors-to-combat-neurodegenerative-diseases
#18
JOURNAL ARTICLE
Hossein Mousavi, Mehdi Rimaz, Behzad Zeynizadeh
Neurodegenerative diseases (NDs) are one of the prominent health challenges facing contemporary society, and many efforts have been made to overcome and (or) control it. In this research paper, we described a practical one-pot two-step three-component reaction between 3,4-dihydronaphthalen-1(2 H )-one ( 1 ), aryl(or heteroaryl)glyoxal monohydrates ( 2a - h ), and hydrazine monohydrate (NH2 NH2 •H2 O) for the regioselective preparation of some 3-aryl(or heteroaryl)-5,6-dihydrobenzo[ h ]cinnoline derivatives ( 3a - h )...
April 22, 2024: ACS Chemical Neuroscience
https://read.qxmd.com/read/38643565/research-progress-of-protacs-for-neurodegenerative-diseases-therapy
#19
REVIEW
Zhifang Cai, Zunhua Yang, Huilan Li, Yuanying Fang
Neurodegenerative diseases (NDD) are characterized by the gradual deterioration of neuronal function and integrity, resulting in an overall decline in brain function. The existing therapeutic options for NDD, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, fall short of meeting the clinical demand. A prominent pathological hallmark observed in numerous neurodegenerative disorders is the aggregation and misfolding of proteins both within and outside neurons. These abnormal proteins play a pivotal role in the pathogenesis of neurodegenerative diseases...
April 18, 2024: Bioorganic Chemistry
https://read.qxmd.com/read/38642804/broken-but-not-beaten-challenge-of-reducing-the-amyloids-pathogenicity-by-degradation
#20
REVIEW
Maksim I Sulatsky, Olga V Stepanenko, Olesya V Stepanenko, Olga I Povarova, Irina M Kuznetsova, Konstantin K Turoverov, Anna I Sulatskaya
BACKGROUND: The accumulation of ordered protein aggregates, amyloid fibrils, accompanies various neurodegenerative diseases (such as Parkinson's, Huntington's, Alzheimer's, etc.) and causes a wide range of systemic and local amyloidoses (such as insulin, hemodialysis amyloidosis, etc.). Such pathologies are usually diagnosed when the disease is already irreversible and a large amount of amyloid plaques have accumulated. In recent years, new drugs aimed at reducing amyloid levels have been actively developed...
April 18, 2024: Journal of Advanced Research
keyword
keyword
18527
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.